Professional Documents
Culture Documents
Dr. P.Pushpangadan
Director National Botanical Research Institute (Council of Scientific & Industrial Research) Lucknow (India)
September 2003
Biodiversity
Biological diversity is the central tenet of nature, one of its key defining features. Evolution has produced an amazing variety of plants, animals and micro-organisms, intricately interconnected, and worthy of respect and conservation in their own right. Biodiversity is also the basis for the continuous evolution of species. This diversity is also the backbone of human societies and cultures, in terms of the ecological functions it provides and the myriad survival and livelihood it meets.
Biodiversity
According to Convention on Biological Diversity (CBD), biodiversity is the variability among all living organisms from all sources, including, inter alia, terrestrial, marine and other aquatic ecosystems and ecological complexes of which they are part; this includes diversity within species, between species and of ecosystems.
Indirect
Non Consumptive
Climate regulation Soil management Waste disposal Nutrient cycling Hydrological regime Species interactions Eco-tourism Recreation Research
Conservation of Biodiversity
Strategies & Priorities
IUCN, UNEP & WWF 1980 came out with the first Global Strategy for Conservation. This Strategy defined conservation as: Management of human use of biodiversity so that it may yield the greatest sustainable benefit to present generation while maintaining its potential to meet the needs and aspirations of future generation This definition involves two complementary components Conservation and sustainability
Century will be the Century of Knowledge A nation s ability to convert knowledge in to wealth and social good through the process of innovation will determine its future ( R A Mashelkar, 2001)
st
TRIPS-CBD Relationship
Absence of explicit compatibility, Difference of approach and priority given to issues which are ultimately related. This has led to violation of the CBD (Articles 8,15 &16). TRIPs ignores a vast range of valuable, traditional knowledge (TK) because it doesn't meet the standards of patentability.
TRIPS-CBD Relationship
(Contd..)
TRIPs undermines CBD in cases of biopiracy, by putting the burden of proof on the source country rather than patentee. Identification of unique source material as required in Art.29 of TRIPs is insufficient. Lack of transparency in the patent application procedure. TRIPs doesn't require the recognition of domestic laws protecting access to genetic resources and TK and subsequent benefit sharing.
Development of international systems of protection of TK. Means for fair & equitable benefit sharing and technology transfer.
Endemic plants (% of
global plants total. 300,000)
Endemic
Vertebrate
species
Mediterranean
Basin
2,362,000
42,123(38.3
25000
13,000(4.3%)
770
235(0.9%)
Sundaland
1,60,000
125,000(7.8)
90,000(72.0)
25,000
15,000(5.0%)
1800
701(2.6%)
Wallacea
347,000
52,020(15.0)
20,415(39.2)
10,000
1500(0.5%)
1142
529(1.9%)
Philippines
300,800
9023(3.0)
3910(43.3)
7620
5832(1.9%)
1093
518(1.9%)
Contd
Plant species
Endemic plants (% of
global plants total. 300,000)
Vertebrate species
Endemic vertebrates
(% of global vertebrates total 27,298)
Indo-Burma SouthCentral China Western Ghats/ Sri Lanka SW Australia New Caledonia New Zealand Polynesia/ Micronesia
2,060,000
10,000(4.9)
100,000(100.0)
13,500
7000(2.3%)
2185
528(1.9%)
800,000
64,000(8.0)
16,562(25.9)
12,000
3500(1.2%)
1141
178(0.7%)
182,500
12,450(6.8)
12,450(100.0)
4780
2180(0.7%)
1073
355(1.3%)
309,850
33,336(10.8)
33,336(100.0)
5469
4331(1.4%)
456
100(0.4%)
18,600
5200(28.0)
526.7(10.1)
3322
2551(0.9%)
190
84(0.3%)
270,500
59,400(22.0)
52,068(87.7)
2300
1865(0.6%)
217
136(0.5%)
46,000
10,024(21.8)
4913(49.0)
6557
3334(1.1%)
342
223(0.8%)
TOTAL
11,558
60,093(20%)
Madagascar
9704(4) 5832(8)
771(4) 518(9)
16.4(8) 64.7(2)
1.3(7) 5.7(2)
9.9(9) 3.0(1)
5 5
*Phillippines
*Sundaland Caribbean Brazils Atlantic Forest Eastern Arc and Coastal Forests of Kenya/Tanz ania *IndoBurma *Western Ghats/ Sri Lanka
5 4 4
1500
121
75.0(1)
6.1(1)
6.7(4)
7000(6)
528(8)
7.0
0.5
4.9(3)
2180
355
17.5(7)
2.9(3)
6.8(5)
* Asia-Pacific countries
Contd
Biodiversity & TK: Bridging the North- South Gap Asia-Pacific Countries should:
Prevent bio-piracy and misappropriation of genetic resources and TK Develop an international system for protection of TK Develop effective mechanisms for fair and equitable benefit sharing and technology transfers
APCTT can help in in Capacity Building and Training for Asia-Pacific countries
STRATEGIES (Contd.):
2. Promotion of multi-country collaborative R&D projects on various facets of Bioprospecting, particularly herbal drug and pharmaceutical prospecting and other natural product development sectors 3. Generation of IPR- covered products, processes, technologies and services, and thereby converting the bio-resources and associated TK in to economic wealth of the country and its people.
Action Programme
Important points that the biodiversity rich third world nations should undertake:
Complete inventory & documentation of all Biological resources including the microorganisms Check list/database of the floristic wealth of the nation along with the associated knowledge system Ground check to know the actual situation and identify the gaps: Study - genetic diversity, distribution pattern, association pattern and gradients Identify- rare, endemic and endangered status of spp. , if any.
Action Programme
Prepare -passport data of all important and endemic biodiversity. Passport data should cover morphological, cytological, chemical and molecular level (DNA/gene level) information so as to prevent bio/gene piracy. Identification of problems and solutions in conservation, threatened status of species, ecosystems -with causes of threats. Identification of problems and solutions in conservation.
BIOPROSPECTING
Chemical prospecting
Drug and pharmaceuticals Pesticides Cosmetics Food additives Other industrially valuable Chemical products
Biodiversity & IK / TK
Bioprospecting
Drug development Pharmaceuticals Nutraceuticals Agro-chemistry Cosmetics/ cosmaceuticals Proteins Enzymes New crop varieties GMOs GM foods Designs, etc.
Conservation
Sustainable use
Benefit sharing
Bioinformatics
IPR